These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

123 related items for PubMed ID: 6340824

  • 1. Eradication of microscopic hepatic metastases by active specific immunization.
    Sukumar S, Hunter JT, Terata N, Rapp HJ.
    Cancer Immunol Immunother; 1983; 14(3):151-4. PubMed ID: 6340824
    [Abstract] [Full Text] [Related]

  • 2. Adjuvant-antigen requirements for active specific immunotherapy of microscopic metastases remaining after surgery.
    Ashley MP, Zbar B, Hunter JT, Rapp HJ, Sugimoto T.
    Cancer Res; 1980 Nov; 40(11):4197-203. PubMed ID: 7471060
    [Abstract] [Full Text] [Related]

  • 3. Eradication by active specific immunotherapy of established tumor transplants and microscopic lymph node metastases.
    Yarkoni E, Ashley MP, Zbar B, Sugimoto T, Rapp HJ.
    Cancer Res; 1982 Jul; 42(7):2544-6. PubMed ID: 7083146
    [Abstract] [Full Text] [Related]

  • 4. Influence of type of oil and surfactant concentration on the efficacy of emulsified Mycobacterium bovis BCG cell walls to induce tumor regression in guinea pigs.
    Yarkoni E, Rapp HJ.
    Infect Immun; 1980 Jun; 28(3):881-6. PubMed ID: 6995325
    [Abstract] [Full Text] [Related]

  • 5. Postoperative active-specific immunotherapy of lymph node micrometastasis in a guinea pig tumor model.
    Bier H, Armonat G, Bier J, Schirrmacher V, Ganzer U.
    ORL J Otorhinolaryngol Relat Spec; 1989 Jun; 51(4):197-205. PubMed ID: 2664632
    [Abstract] [Full Text] [Related]

  • 6. Immunotherapy of guinea pigs with dermal and visceral tumor implants: comparison of living and nonliving BCG.
    Yarkoni E, Peters L, Rapp HJ, Hanna MG, Hunter JT.
    Infect Immun; 1979 May; 24(2):565-66. PubMed ID: 378859
    [Abstract] [Full Text] [Related]

  • 7. A comparison of in vitro cell-mediated reactivity against syngeneic tumor cells by various lymphoid cell populations from Bacillus Calmette-Guérin-tumor-cured, tumor-sensitized, tumor-bearing, and normal inbred guinea pigs.
    Fidler IJ, Kataoka T, Hanna MG.
    Cancer Res; 1976 Dec; 36(12):4459-66. PubMed ID: 187324
    [Abstract] [Full Text] [Related]

  • 8. Histological evaluation of immunologically mediated tumor regression of the line 10 guinea pig hepatocarcinoma.
    de Jong WH, Teppema JS, Wagenaar SS, Paques M, Steerenberg PA, Ruitenberg EJ.
    Virchows Arch B Cell Pathol Incl Mol Pathol; 1986 Dec; 50(3):249-69. PubMed ID: 2870577
    [Abstract] [Full Text] [Related]

  • 9. Suppression and immunotherapy of the guinea pig line 10 hepatocarcinoma mediated by heat-killed disrupted Mycobacterium bovis strain Bacillus Calmette-Guérin.
    Minden P, Mathews HL.
    Cancer Res; 1980 Sep; 40(9):3214-7. PubMed ID: 6159072
    [Abstract] [Full Text] [Related]

  • 10. Eradication of microscopic lymph nodes metastases after injection of living BCG adjacent to the primary tumor.
    Smith HG, Bast RC, Zbar B, Rapp HJ.
    J Natl Cancer Inst; 1975 Dec; 55(6):1345-52. PubMed ID: 1107574
    [Abstract] [Full Text] [Related]

  • 11. Immunotherapy of guinea pigs with a transplanted hepatoma: comparison of intralesionally administered killed BCG cells and BCG cell walls.
    Yarkoni E, Rapp HJ.
    Infect Immun; 1979 Sep; 25(3):1087-9. PubMed ID: 387592
    [Abstract] [Full Text] [Related]

  • 12. Regression by active specific immunotherapy of established dermal tumor transplants and lymph node metastases in guinea pigs.
    Yarkoni E, Rapp HJ.
    Infect Immun; 1981 Jan; 31(1):514-6. PubMed ID: 7216457
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Immunotherapy of experimental cancer by intralesional injection of emulsified nonliving mycobacteria: comparison of Mycobacterium bovis (BCG), Mycobacterium phlei, and Mycobacterium smegmatis.
    Yarkoni E, Rapp HJ.
    Infect Immun; 1980 Jun; 28(3):887-92. PubMed ID: 6995326
    [Abstract] [Full Text] [Related]

  • 16. A specific vaccine effective against stage I and stage II malignant disease in guinea pigs. Effect of variations in preparations and storage.
    Yarkoni E, Hunter JT, Sukumar S.
    Cancer Immunol Immunother; 1982 Jun; 14(2):92-5. PubMed ID: 6965232
    [Abstract] [Full Text] [Related]

  • 17. Active specific immunotherapy of established micrometastasis: effect of cryopreservation procedures on tumor cell immunogenicity in guinea pigs.
    Peters LC, Hanna MG.
    J Natl Cancer Inst; 1980 Jun; 64(6):1521-5. PubMed ID: 6990075
    [Abstract] [Full Text] [Related]

  • 18. Evaluation of BCG administered by scarification for immunotherapy of metastatic hepatocarcinoma in the guinea pig.
    Hanna MG, Peters LC, Gutterman JU, Hersh EM.
    J Natl Cancer Inst; 1976 May; 56(5):1013-7. PubMed ID: 186611
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.